10-Q: Adtalem Reports Strong Q2 FY26 Earnings Amid Regulatory Shifts

Adtalem Global Education Inc. announced a 12.4% revenue increase and significant adjusted earnings growth for Q2 FY26, alongside ongoing navigation of new federal student aid regulations.

Summary

• Revenue for the second quarter of fiscal year 2026 increased by 12.4% to $503.4 million, compared to $447.7 million in the prior year period.
• Net income rose by 0.7% to $76.4 million in Q2 FY26, up from $75.9 million in the prior year.
• Diluted earnings per share (EPS) increased by 6.6% to $2.11 for Q2 FY26, compared to $1.98 in the prior year, driven by higher net income and lower diluted shares due to share repurchases.
• Adjusted net income saw a substantial increase of 26.7% to $87.9 million, up from $69.4 million in the prior year period.
• Adjusted diluted EPS grew by 34.3% to $2.43 in Q2 FY26, compared to $1.81 in the prior year, reflecting the increase in adjusted net income and reduced share count.
• Walden University's total student enrollment increased by 13.0% as of December 31, 2025, compared to the prior year.
• Medical and Veterinary schools' total student enrollment increased by 2.4% for the September 2025 semester.
• Chamberlain University's total student enrollment decreased by 1.0% for the November 2025 session, with pre-licensure growth offset by a decline in post-licensure programs.
• The company repurchased 1,727,565 shares of common stock at an average cost of $95.45 per share during Q2 FY26, totaling $164.9 million.
• Adtalem completed its fifteenth share repurchase program and authorized a new sixteenth program for up to $750.0 million through December 15, 2028, with $727.5 million remaining as of December 31, 2025.
• The One Big Beautiful Bill Act (OBBBA), signed in July 2025, introduces significant changes to federal student aid, including increased loan limits for professional programs, phasing out Grad PLUS loans, new aggregate loan caps, and 'Do No Harm' provisions, with the full impact yet to be determined pending implementing regulations.
• Adtalem's institutions are operating under provisional certifications for Title IV aid due to a fiscal year 2022 composite financial responsibility score of 0.2, requiring heightened cash monitoring and $202.6 million in surety-backed letters of credit.

Sentiment

Score: 7

Explanation: The company reported strong revenue and adjusted earnings growth, indicating solid operational performance. However, significant regulatory uncertainties from OBBBA and GE rules, along with a decline in Chamberlain's enrollment and a substantial decrease in cash, temper the overall positive sentiment. The aggressive share repurchase program and proactive capital structure review are positive signals.

Positives

• Consolidated revenue increased by 12.4% to $503.4 million in Q2 FY26, demonstrating strong top-line growth.
• Adjusted net income surged by 26.7% to $87.9 million, and adjusted diluted EPS increased by 34.3% to $2.43, indicating improved profitability and efficiency.
• Walden University experienced robust student enrollment growth of 13.0% as of December 31, 2025.
• Medical and Veterinary schools also showed positive enrollment growth of 2.4% for the September 2025 semester.
• Interest expense decreased by $2.992 million in Q2 FY26, primarily due to lower Term Loan B borrowings and a reduced interest rate.
• The company authorized a new $750.0 million share repurchase program, signaling confidence in future performance and commitment to shareholder returns.
• Cost of educational services as a percentage of revenue decreased from 41.7% to 40.8% in Q2 FY26, reflecting cost efficiencies.

Negatives

• Chamberlain University's total student enrollment decreased by 1.0% in the November 2025 session, primarily due to a decline in post-licensure nursing programs.
• Cash and cash equivalents significantly decreased from $199.6 million at June 30, 2025, to $56.3 million at December 31, 2025.
• Restructuring expense increased to $4.1 million in Q2 FY26 from $0.3 million in the prior year, driven by workforce reductions.
• Student services and administrative expense increased by 16.5% in Q2 FY26, partly due to higher strategic advisory costs and marketing expenses.
• Income from discontinued operations decreased significantly to $0.2 million in Q2 FY26 from $4.7 million in the prior year, as the DeVry University earn-out was fully received.

Risks

• The One Big Beautiful Bill Act (OBBBA), enacted in July 2025, introduces substantial changes to federal student aid, including new aggregate loan caps and 'Do No Harm' provisions, which could materially adversely affect the business, financial condition, cash flows, or results of operations, as implementing regulations are still pending.
• Adtalem's institutions are provisionally certified for Title IV aid due to a fiscal year 2022 composite financial responsibility score of 0.2, requiring heightened cash monitoring and $202.6 million in surety-backed letters of credit, with potential for additional requirements under new ED regulations.
• New Financial Value Transparency (FVT) and Gainful Employment (GE) rules, effective July 1, 2024, require programs to meet debt-to-earnings and earnings premium tests, with failure potentially leading to loss of Title IV eligibility; the full impact is still being evaluated, and the rules are subject to ongoing legal challenges and potential amendments.
• Borrower Defense to Repayment (BDR) claims continue to be filed against Adtalem's institutions (totaling 14,984 claims across five institutions), with potential financial liability risk and reputational risk, although the 2022 BDR regulations were delayed until July 1, 2035.
• The company's ability to maintain sufficient liquidity may be affected by numerous factors outside its control, despite current projections of adequate funding.
• If economic conditions deteriorate or operating performance of reporting units does not meet expectations, the company may recognize impairments of goodwill and other intangible assets in future periods.

Future Outlook

The company is actively evaluating the impact of the One Big Beautiful Bill Act (OBBBA) and its forthcoming implementing regulations on its operations and student financial aid. Management anticipates that potential relationships with other financing sources will result in loan programs to replace funding limited by OBBBA. The company is also reviewing and planning strategic alternatives to refinance or optimize its capital structure, which may include issuing debt, equity, or other securities, or entering into new credit facilities. Management believes current cash flows, existing cash balances, and available credit will provide sufficient liquidity for the next twelve months and several years.

Management Comments

• Management is focused on optimizing marketing and enrollment operations to address post-licensure enrollment declines at Chamberlain University.
• Management continues to focus on increasing enrollment and renewing operational effectiveness, specifically around academic support and the enrollment experience for Medical and Veterinary schools.
• Management does not believe the provisional certification conditions for Title IV aid will have a material adverse effect on Adtalem's operations.
• Management believes a student's status provides the best credit loss estimate for accounts receivables, while delinquency provides the best credit loss estimate for financing receivables.

Industry Context

The higher education industry, particularly proprietary institutions, faces significant regulatory changes with the enactment of the One Big Beautiful Bill Act (OBBBA) and new Gainful Employment (GE) rules. These changes, including federal student aid limits and 'Do No Harm' provisions, are creating an uncertain environment for student enrollment and financial models. Adtalem's proactive engagement with alternative financing sources and its focus on operational efficiencies and student experience are critical responses to these evolving industry dynamics. The application of the same rules to all Title IV institutions under OBBBA could level the playing field for proprietary education providers.

Comparison to Industry Standards

• NA

Management Changes

Corporate Governance

Legal Proceedings

• Adtalem is subject to lawsuits, administrative proceedings, regulatory reviews, and investigations associated with financial assistance programs and other business matters.
• The company has adequately reserved for matters where a loss is probable and estimable as of December 31, 2025.
• Borrower Defense to Repayment (BDR) applications have been filed by students against AUC (336), Chamberlain (3,144), RUSM (1,745), RUSVM (1,905), and Walden (7,804) seeking federal student loan forgiveness. The institutions have responded, believing claims are ineligible, and no ED notice of approvals or recoupment intent has been received.
• A federal district judge ruled in ED's favor on October 2, 2025, upholding the Financial Value Transparency (FVT) and Gainful Employment (GE) rules, though the decision is subject to appeal.

Related Party Transactions

• NA

Stakeholder Impact

• Shareholders: Positive impact from strong adjusted earnings growth and significant share repurchase programs, but potential uncertainty from regulatory changes and cash flow reduction.
• Employees: Impacted by workforce reductions contributing to restructuring expenses, but also benefit from stock-based compensation plans and new insider trading policies.
• Students: Directly affected by changes in federal student aid programs (OBBBA, Grad PLUS phase-out, loan caps) and the outcome of Gainful Employment rules and Borrower Defense to Repayment claims, which could influence their ability to fund education.
• Creditors: Long-term debt has been reduced, and the company maintains a $500.0 million revolving credit facility, indicating a stable debt position, but the review of capital structure optimization suggests potential future changes.
• Regulatory Authorities: The company is under close scrutiny from the U.S. Department of Education due to its financial responsibility composite score and is actively navigating new and evolving regulations.

Next Steps

• Continue to analyze the changes made by OBBBA and the regulations being promulgated to implement it.
• Engage in discussions with other financing sources to provide loan programs for students to replace funding limited by OBBBA.
• Review and plan strategic alternatives to refinance or optimize the capital structure, potentially including issuing debt, equity, or new credit facilities.
• Monitor and respond to Borrower Defense to Repayment (BDR) claims.
• Address post-licensure enrollment declines at Chamberlain University through optimized marketing and enrollment operations.
• Continue efforts to increase enrollment and renew operational effectiveness in Medical and Veterinary schools, focusing on academic support and enrollment experience.
• The negotiating committee addressing FVT/GE rules met in December 2025 and January 2026, with further developments expected.

Key Dates

Recommendation

Adtalem's Q2 FY26 results show strong revenue and adjusted earnings growth, driven by Walden and Medical/Veterinary segments, and a commitment to shareholder returns through significant share repurchases. This operational strength and capital allocation strategy are positive. However, the decline in Chamberlain's enrollment and a substantial reduction in cash and cash equivalents warrant caution. More importantly, the significant and evolving regulatory landscape, particularly the One Big Beautiful Bill Act (OBBBA) and Gainful Employment (GE) rules, introduces considerable uncertainty regarding future student enrollment and financial aid eligibility. While the company is actively addressing these challenges, the full impact is not yet clear. Given the mixed operational performance and the material, unresolved regulatory risks, a 'hold' recommendation is appropriate until there is greater clarity on the long-term implications of these external factors.

Keywords

Higher Education, SEC Filing, Financial Results, Enrollment, Student Aid, Regulatory Risk, Share Repurchase, Adtalem, ATGE, Chamberlain University, Walden University, Medical Schools, Veterinary Schools, OBBBA, Gainful Employment, Borrower Defense